NEW CYTOSTATICS - MORE ACTIVITY AND LESS TOXICITY

被引：20

作者：

BERGER, MR ^{[1
]}

RICHTER, H ^{[1
]}

SEELIG, MH ^{[1
]}

EIBL, H ^{[1
]}

SCHMAHL, D ^{[1
]}

机构：

[1] MAX PLANCK INST BIOPHYS CHEM,W-3400 GOTTINGEN,GERMANY

来源：

CANCER TREATMENT REVIEWS | 1990年 / 17卷 / 2-3期

关键词：

D O I：

10.1016/0305-7372(90)90039-I

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：143 / 154

页数：12

共 24 条

[1]

ATASSI G, 1984, EUR J CANCER CLIN ON, V20, P1217, DOI 10.1016/0277-5379(84)90249-9

[2]

BARBACID M, 1986, ACCOMPLISHMENS CANCE, P179

[3]

BERDEL WE, 1985, PHOSPHOLIPIDS CELLUL, V2, P41

[4] NONCARCINOGENIC CHEMOTHERAPY WITH A COMBINATION OF VINCRISTINE, METHOTREXATE AND 5-FLUOROURACIL (VMF) IN RATS [J].

BERGER, M ;

HABS, M ;

SCHMAHL, D .

INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (02) :231-236

[5] ESTROGEN-LINKED 2-CHLOROETHYLNITROSOUREAS - ANTICANCER EFFICACY IN MNU-INDUCED RAT MAMMARY-CARCINOMA, UTERINE ACTIVITY IN MICE AND RECEPTOR INTERACTIONS [J].

BERGER, MR ;

FLORIDE, J ;

SCHMAHL, D ;

SCHREIBER, J ;

EISENBRAND, G .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (10) :1179-1191

[6] INFLUENCE OF THE ALKYLLYSOPHOSPHOLIPID ET-18-OCH3 ON METHYLNITROSOUREA-INDUCED RAT MAMMARY CARCINOMAS [J].

BERGER, MR ;

MUNDER, PG ;

SCHMAHL, D ;

WESTPHAL, O .

ONCOLOGY, 1984, 41 (02) :109-113

[7]

BERGER MR, 1985, CANCER TREAT REP, V69, P1415

[8] NEW CYTOSTATICS WITH EXPERIMENTALLY DIFFERENT TOXIC PROFILES [J].

BERGER, MR ;

MUSCHIOL, C ;

SCHMAHL, D ;

EIBL, HJ .

CANCER TREATMENT REVIEWS, 1987, 14 (3-4) :307-317

[9]

BERGER MR, 1986, HEPATO-GASTROENTEROL, V33, P227

[10]

CORBETT TH, 1987, INVEST NEW DRUG, V5, P3

← 1 2 3 →